CMS, FDA officials ramp up AI efforts as clinicians debate risks

CMS is pursuing an ambitious AI agenda while key questions remain about balancing innovation with evidence, safety, and appropriate human oversight. The article examines regulatory efforts by federal agencies to advance AI adoption in healthcare amid ongoing clinical concerns.